Medroxyprogesterone acetate‐treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV‐1 susceptibility Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • ProblemMedroxyprogesterone acetate (MPA), a progestin‐based hormonal contraceptive designed to mimic progesterone, has been linked to increased human immunodeficiency virus (HIV‐1) susceptibility. Genital epithelial cells (GECs) form the mucosal lining of the female genital tract (FGT) and provide the first line of protection against HIV‐1. The impact of endogenous sex hormones or MPA on the gene expression profile of GECs has not been comprehensively documented.Method of studyUsing microarray analysis, we characterized the transcriptional profile of primary endometrial epithelial cells grown in physiological levels of E2, P4, and MPA.ResultsEach hormone treatment altered the gene expression profile of GECs in a unique manner. Interestingly, although MPA is a progestogen, the gene expression profile induced by it was distinct from P4. MPA increased gene expression of genes related to inflammation and cholesterol synthesis linked to innate immunity and HIV‐1 susceptibility.ConclusionThe analysis of gene expression profiles provides insights into the effects of sex hormones and MPA on GECs and allows us to posit possible mechanisms of the MPA‐mediated increase in HIV‐1 acquisition.


  • Woods, Matthew W
  • Zahoor, Muhammad Atif
  • Dizzell, Sara
  • Verschoor, Chris P
  • Kaushic, Charu

publication date

  • January 2018